pharma · Asthma · Osteoarthritis · AMRX
Amneal Pharma Europe
Amneal Pharma Europe Ltd
Amneal Pharma Europe is a pharma organization headquartered in Bridgewater, USA. It trades on NYSE under ticker AMRX. Primary therapeutic focus areas include Asthma, Osteoarthritis, Schizophrenia, Open-angle Glaucoma, Pa
400 Crossing Boulevard, Bridgewater, New Jersey 08807, US HQ
2002 Founded
7,179 Employees
Public company Type
AMRX · NYSE Ticker
Company details
- Status
- Public
- HQ
- 400 Crossing Boulevard, Bridgewater, New Jersey 08807, US
- Founded
- 2002
- Employees
- 7,179
- Programs
- 15
- Drugs
- 210
- Patents
- 32
Imatinib Mesylate Tablets, 400 mg
Phase 3 · small molecule · Chronic Myeloid Leukemia
Imatinib Mesylate Tablets, 400 mg for Chronic Myeloid Leukemia is a Phase 3 program (small_molecule) at Amneal Pharma Europe Ltd with 1 ClinicalTrials.gov record(s).
Internal code ARL/CT/13/001
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Amneal Pharma Europe Ltd
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Chronic Myeloid Leukemia
- Status
- completed
- Trials
- 1